Halothane hepatitis: a case report.

Br J Anaesth

St Thomas' Hospital, London.

Published: March 1990

This report describes a patient who required 12 anaesthetics over a period of 25 yr. Halothane was used on at least five occasions. The first documented halothane anaesthetic was followed by jaundice. Subsequently, he received at least four halothane anaesthetics, all of which were followed by illness attributable possibly to hepatotoxicity. He also received five nonhalothane anaesthetics, none of which was followed by postoperative illness. This case history shows strong evidence of halothane causing hepatotoxicity. It also shows an inverse relationship between the severity of the disease and the interval between halothane exposures. It is presented as evidence in favour of the advice on using halothane issued by the Committee on Safety of Medicines.

Download full-text PDF

Source
http://dx.doi.org/10.1093/bja/64.3.358DOI Listing

Publication Analysis

Top Keywords

halothane
7
halothane hepatitis
4
hepatitis case
4
case report
4
report report
4
report describes
4
describes patient
4
patient required
4
required anaesthetics
4
anaesthetics period
4

Similar Publications

Surgery remains the primary treatment for solid malignant tumors, but controlling postoperative tumor recurrence and metastasis continues to be a major challenge. Understanding the factors that influence tumor recurrence and metastasis after surgery, as well as the underlying biological mechanisms, is critical. Previous studies suggest that anesthetic agents may increase the risk of tumor recurrence and metastasis in patients with cancer, but the mechanisms underlying these findings remain unclear.

View Article and Find Full Text PDF

Malignant hyperthermia (MH) is a potentially fatal disorder triggered by volatile anesthetics or succinylcholine, inducing a hypermetabolic crisis in susceptible patients. The caffeine-halothane contracture test (CHCT) remains a gold standard for MH detection. The authors describe a pregnant patient with a history of exertional rhabdomyolysis, who required urgent MH screening for administration of MH-triggering anesthetics.

View Article and Find Full Text PDF

Background: Jenacid Herbal Product (JHP) used for treating peptic ulcer disease in Uganda, sold over the counter, is approved by the National Drug Authority as a Traditional Herbal Product number THP 482. There have been no published studies on its safety and efficacy.

Objective: This study aimed to assess potential acute and subacute toxicity as well as the efficacy of JHP.

View Article and Find Full Text PDF

In this study, we develop the synthesis methods of fluoroalkenes and fluoroenynes via Suzuki-Miyaura and Sonogashira cross-coupling reactions using novel multihalogenated fluorovinyl ethers, which are easily prepared from the reaction between phenols and 2-bromo-2-chloro-1,1,1-trifluoroethane (halothane). These reactions make use of the unique structure of multihalogenated fluorovinyl ethers, which contains a reactive bromine atom, to afford a series of fluoroalkenes and fluoroenynes in moderate to high yields.

View Article and Find Full Text PDF

Doxorubicin (DOX) is a widely used anticancer agent, but its clinical application is limited by significant off-target hepatorenal toxicity. Tadalafil (TAD), a selective phosphodiesterase-5 inhibitor used mainly for erectile dysfunction and pulmonary arterial hypertension, has shown potential in reducing oxidative stress. This study investigated TAD's chemoprotective effects and underlying mechanisms in DOX-induced hepatorenal toxicity in rats over 12 days.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!